Suchergebnisse - "De Schryver, Nicolas"

PubPharm (38)

1

Correction : Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

enthalten in: Intensive care medicine | 2024

von Pickkers, P. | Angus, D. | Bass, K. | +118

ErratumFor: Intensive Care Med. 2024 Jan;50(1):68-78. - PMID 38172296

2

Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

enthalten in: Intensive care medicine | 2024

von Pickkers, P. | Angus, D. | Bass, K. | +118

ErratumIn: Intensive Care Med. 2024 Mar 4;:. - PMID 38436728

3

Case Report : Late Reactivation of Herpes B Virus After a Monkey Bite: A Case of Severe Meningoencephalitis

enthalten in: The American journal of tropical medicine and hygiene | 2023

von Ponzetto, E. | Delhez, Q. | Hoppenbrouwers, M. | +10

4

Early mobilisation in critically ill COVID-19 patients : a subanalysis of the ESICM-initiated UNITE-COVID observational study

enthalten in: Annals of intensive care | 2023

von Kloss, P. | Lindholz, M. | Milnik, A. | +117

5

Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients

enthalten in: The New England journal of medicine | 2023

von Misset, B. | Piagnerelli, M. | Hoste, E. | +27

CommentIn: N Engl J Med. 2024 Jan 25;390(4):384-385. - PMID 38265659

6

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH) : a double-blind, randomised, controlled, phase 2b trial

enthalten in: The Lancet. Respiratory medicine | 2023

von François, B. | Lambden, S. | Fivez, T. | +50

CommentIn: Lancet Respir Med. 2023 Oct;11(10):855-857. - PMID 37269869

7

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients : a randomised controlled trial

enthalten in: Critical care (London, England) | 2022

von Chastre, J. | François, B. | Bourgeois, M. | +115

8

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

enthalten in: Critical care | 2022

von Chastre, J. | François, B. | Bourgeois, M. | +35

9

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

enthalten in: Critical care | 2022

von Chastre, J. | François, B. | Bourgeois, M. | +35

10

Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients : a descriptive analysis of the Eurobact II study

enthalten in: Critical care (London, England) | 2022

von Buetti, N. | Tabah, A. | Loiodice, A. | +120